Adaptive metabolic strategies of intracellular bacterial pathogens
Frontiers in Microbiology · 31.03.2026 · 17
DOI: 10.3389/fmicb.2026.1783835 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 31.03.2026. Verfasst von Tripti Nair und 7 weiteren Autor:innen. Beteiligte Einrichtung: Leonard Davis School of Gerontology, University of Southern California, Los Angeles, , CA, United States. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intracellular bacterial pathogens have evolved sophisticated metabolic strategies to persist and replicate within the hostile intracellular environments of their hosts. By leveraging their metabolic plasticity, these pathogens dynamically modulate host metabolic processes in response to immunological, environmental, and pharmacological stressors. This review examines the diverse metabolic adaptations employed by intracellular pathogens, including nutrient acquisition, modulation of host metabolism, and stress-induced metabolic shifts that contribute to persistence and virulence. Emphasis is placed on how distinct intracellular niches- such as vacuoles and the cytosol- shape pathogen metabolism, and how bipartite metabolic strategies enable pathogens to balance energy production with biosynthetic demands. Species-specific adaptations in representative pathogens, including Listeria monocytogenes , Legionella pneumophila , Shigella flexneri , and Chlamydia trachomatis , are analyzed, with a focus on mechanisms of metabolic reprogramming (the alteration of cellular metabolic pathways in response to environmental cues, such as infection or stress, which allows the pathogen to adapt its metabolic state to support survival, replication, and virulence within the host), stress tolerance (refers to a pathogen’s ability to survive and function under harsh environmental conditions, such as oxidative stress, nutrient scarcity, and antimicrobial exposure), and lifecycle transitions (refer to the changes in a pathogen’s developmental or replication stages, such as switching from active growth to a dormant or persistent state during infection). Finally, the review considers how these metabolic strategies intersect with antimicrobial resistance and highlights the potential of targeting host-pathogen metabolic interactions for the development of novel interventions, including host-directed therapies (HDTs).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Leonard Davis School of Gerontology, University of Southern California, Los Angeles, , CA, United States.
- Departments of Biomedical Engineering, New York University Tandon School of Engineering, Brooklyn, NY, United States.
- Department of Medicine and Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
- Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
- Humankine, New Product Development, Proteintech Group Inc., Rosemont, IL, United States.
- Department of Cell and Developmental Biology, Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY, United States.
Zitieren
APA
Nair, T., Rosenn, E. H., Singha, B., Shukla, S., Vashisht, S., Upadhyay, A., Padmanarayana, M., & Soni, V. (2026). Adaptive metabolic strategies of intracellular bacterial pathogens. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1783835
Vancouver
Nair T, Rosenn EH, Singha B, Shukla S, Vashisht S, Upadhyay A, et al. Adaptive metabolic strategies of intracellular bacterial pathogens. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1783835
BibTeX
@article{Nair2026,
author = {Nair, Tripti and Rosenn, Eric H and Singha, Biplab and Shukla, Shagun and Vashisht, Sharad and Upadhyay, Aditya and Padmanarayana, Murugesh and Soni, Vijay},
title = {Adaptive metabolic strategies of intracellular bacterial pathogens},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1783835}
}
EUVIMED